Skip to main content
Figure 4 | Molecular Pain

Figure 4

From: Intrathecal leptin inhibits expression of the P2X2/3 receptors and alleviates neuropathic pain induced by chronic constriction sciatic nerve injury

Figure 4

Leptin administration decreases the immunoreactivities of P2X 2 and P2X 3 receptors in L4-6 DRG of CCI rats. Leptin administration decreased the immunoreactivity of P2X2(A) and P2X3(B) receptors within the DRG of CCI rats. P2X2 and P2X3 receptors immunoreactivity (brown) was detected in DRG neurons of sham, CCI + vehicle, CCI + Leptin (10 μg), CCI + Leptin (50 μg) and CCI + Leptin (200 μg) treatments. Leptin was intrathecally delivered once daily for 6 days beginning 7 days after CCI. The rats were sacrificed 24 h after the last leptin administration. Arrows indicate P2X2 and P2X3 receptor positive neurons. Scale bar is 20 μm. Data are shown as mean ± S.E.M, n = 5. *P < 0.05, and #P < 0.01 vs CCI + Vehicle group.

Back to article page

Molecular Pain

ISSN: 1744-8069

Contact us